Wilkins Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.08M | Buy |
180,975
+1,620
| +0.9% | +$43.1K | 0.73% | 44 |
|
|
2025
Q4 | $4.47M | Sell |
179,355
-20,005
| -10% | -$504K | 0.65% | 46 |
|
|
2025
Q3 | $5.08M | Sell |
199,360
-2,850
| -1% | -$70.3K | 0.72% | 42 |
|
|
2025
Q2 | $4.9M | Sell |
202,210
-3,376
| -2% | -$78.7K | 0.69% | 42 |
|
|
2025
Q1 | $5.21M | Sell |
205,586
-53,100
| -21% | -$1.39M | 0.75% | 42 |
|
|
2024
Q4 | $6.86M | Sell |
258,686
-5,248
| -2% | -$142K | 0.99% | 36 |
|
|
2024
Q3 | $7.64M | Buy |
263,934
+2,700
| +1% | +$78.8K | 1.06% | 36 |
|
|
2024
Q2 | $7.31M | Buy |
261,234
+4,183
| +2% | +$115K | 1.09% | 36 |
|
|
2024
Q1 | $7.13M | Buy |
257,051
+153,890
| +149% | +$4.27M | 1.04% | 35 |
|
|
2023
Q4 | $2.97M | Buy |
103,161
+1,000
| +1% | +$30.2K | 0.72% | 40 |
|
|
2023
Q3 | $3.39M | Sell |
102,161
-688
| -0.7% | -$24.3K | 0.92% | 37 |
|
|
2023
Q2 | $3.77M | Sell |
102,849
-7,400
| -7% | -$288K | 0.99% | 37 |
|
|
2023
Q1 | $4.5M | Buy |
110,249
+600
| +0.5% | +$25.9K | 1.18% | 35 |
|
|
2022
Q4 | $5.62M | Sell |
109,649
-315
| -0.3% | -$15.1K | 1.48% | 33 |
|
|
2022
Q3 | $4.81M | Hold |
109,964
| – | – | 1.41% | 33 |
|
|
2022
Q2 | $5.76M | Sell |
109,964
-2,500
| -2% | -$127K | 1.53% | 31 |
|
|
2022
Q1 | $5.82M | Sell |
112,464
-1,307
| -1% | -$67.8K | 1.31% | 35 |
|
|
2021
Q4 | $6.72M | Sell |
113,771
-1,000
| -0.9% | -$49.5K | 1.48% | 32 |
|
|
2021
Q3 | $4.94M | Hold |
114,771
| – | – | 1.21% | 36 |
|
|
2021
Q2 | $4.49M | Sell |
114,771
-600
| -0.5% | -$23.3K | 1.11% | 34 |
|
|
2021
Q1 | $4.18M | Sell |
115,371
-3,800
| -3% | -$135K | 1.08% | 32 |
|
|
2020
Q4 | $4.39M | Sell |
119,171
-9,070
| -7% | -$333K | 1.21% | 32 |
|
|
2020
Q3 | $4.46M | Hold |
128,241
| – | – | 1.33% | 31 |
|
|
2020
Q2 | $3.98M | Sell |
128,241
-422
| -0.3% | -$14.3K | 1.26% | 32 |
|
|
2020
Q1 | $3.98M | Sell |
128,663
-2,233
| -2% | -$76.1K | 1.45% | 28 |
|
|
2019
Q4 | $4.87M | Hold |
130,896
| – | – | 1.38% | 29 |
|
|
2019
Q3 | $4.46M | Buy |
130,896
+843
| +0.6% | +$30.7K | 1.34% | 30 |
|
|
2019
Q2 | $5.34M | Sell |
130,053
-2,951
| -2% | -$117K | 1.6% | 28 |
|
|
2019
Q1 | $5.36M | Sell |
133,004
-5,270
| -4% | -$211K | 1.62% | 27 |
|
|
2018
Q4 | $5.73M | Sell |
138,274
-106
| -0.1% | -$4.4K | 1.9% | 23 |
|
|
2018
Q3 | $5.79M | Sell |
138,380
-3,056
| -2% | -$118K | 1.73% | 27 |
|
|
2018
Q2 | $4.87M | Sell |
141,436
-57,993
| -29% | -$1.98M | 1.53% | 27 |
|
|
2018
Q1 | $6.71M | Sell |
199,429
-78,947
| -28% | -$2.71M | 2.12% | 22 |
|
|
2017
Q4 | $9.57M | Sell |
278,376
-8,356
| -3% | -$285K | 2.86% | 13 |
|
|
2017
Q3 | $9.71M | Sell |
286,732
-371
| -0.1% | -$11.9K | 2.95% | 13 |
|
|
2017
Q2 | $9.15M | Sell |
287,103
-1,354
| -0.5% | -$42.7K | 2.91% | 12 |
|
|
2017
Q1 | $9.36M | Buy |
288,457
+4,854
| +2% | +$153K | 3% | 11 |
|
|
2016
Q4 | $8.74M | Buy |
283,603
+12,226
| +5% | +$373K | 2.79% | 14 |
|
|
2016
Q3 | $8.72M | Buy |
271,377
+2,249
| +0.8% | +$75.2K | 2.93% | 11 |
|
|
2016
Q2 | $8.99M | Buy |
269,128
+2,108
| +0.8% | +$67.3K | 3.04% | 9 |
|
|
2016
Q1 | $7.51M | Buy |
267,020
+18,329
| +7% | +$524K | 2.75% | 14 |
|
|
2015
Q4 | $7.62M | Sell |
248,691
-10,435
| -4% | -$328K | 2.86% | 12 |
|
|
2015
Q3 | $7.72M | Sell |
259,126
-211
| -0.1% | -$6.76K | 2.95% | 9 |
|
|
2015
Q2 | $8.25M | Sell |
259,337
-1,475
| -0.6% | -$48.1K | 3.01% | 9 |
|
|
2015
Q1 | $8.61M | Sell |
260,812
-182
| -0.1% | -$5.79K | 3.04% | 7 |
|
|
2014
Q4 | $7.71M | Sell |
260,994
-2,826
| -1% | -$81K | 2.68% | 13 |
|
|
2014
Q3 | $7.4M | Sell |
263,820
-633
| -0.2% | -$17.8K | 2.64% | 14 |
|
|
2014
Q2 | $7.45M | Sell |
264,453
-18,577
| -7% | -$530K | 2.63% | 15 |
|
|
2014
Q1 | $8.63M | Buy |
283,030
+224
| +0.1% | +$6.68K | 3.18% | 4 |
|
|
2013
Q4 | $8.22M | Buy |
282,806
+14,161
| +5% | +$412K | 3.41% | 6 |
|
|
2013
Q3 | $7.32M | Sell |
268,645
-4,877
| -2% | -$133K | 3.34% | 7 |
|
|
2013
Q2 | $7.27M | Buy |
+273,522
| New | +$7.56M | 3.37% | 6 |
|
Other funds holding PFE
VCM
VPM
Wilkins Investment Counsel's PFE Position: Q1 2026 in Review
Wilkins Investment Counsel increased its Pfizer (PFE) stake by 0.9% in Q1 2026, buying an estimated $43.1K and bringing the position to 180,975 shares worth $5.08M. The position accounts for 0.73% of the portfolio, ranked #44.
Wilkins Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.71M in Q3 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wilkins Investment Counsel held 180,975 shares of Pfizer worth $5.08M as of Q1 2026.
- Wilkins Investment Counsel bought 1,620 Pfizer shares in Q1 2026, an estimated $43.1K.
- Pfizer made up 0.73% of Wilkins Investment Counsel's portfolio in Q1 2026, its #44 holding.
- Wilkins Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Wilkins Investment Counsel's Pfizer position peaked at $9.71M in Q3 2017.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.